FIELD: medicine, pharmaceutics.
SUBSTANCE: described are novel derivatives of hexahydro pyrazino [2,1-c][1,2,4]triazine of general formula (III) (values of radicals are given in invention formula), their pharmaceutically acceptable salts and application of said compounds for obtaining medication for treatment and prevention of acute myeloid leukemia.
EFFECT: obtaining medication for treatment and prevention of acute myeloid leukemia
3 cl, 3 ex, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOUNDS MIMETICS AND USING THEM | 2008 |
|
RU2457210C2 |
MIMETICS WITH REVERSE CONFIGURATIONS AND METHODS OF THEIR ADMINISTRATION | 2004 |
|
RU2342387C2 |
PEPTIDILE HETEROCYCLES USED TO TREAT THROMBIN- ASSOCIATED DISEASES | 1996 |
|
RU2181125C2 |
MODULATION OF BETA-CATENIN/TCF-ACTIVATED TRANSCRIPTION | 2004 |
|
RU2383547C2 |
DERIVATIVES OF THIOPHEN AND PHARMACEUTICAL COMPOSIITON (VERSIONS) | 2003 |
|
RU2359967C2 |
HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES | 2005 |
|
RU2405778C2 |
PIPERIDINE/PIPERAZINE DERIVATIVES | 2008 |
|
RU2470017C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
3,7-DIAZABICYCLO[3.3.0]OCTANES AND THEIR USING IN TREATMENT OF CARDIAC ARRHYTHMIA | 2002 |
|
RU2293085C2 |
NEW COMPOUNDS AS MODULATOR OF OPIOTIC RECEPTORS | 2003 |
|
RU2332411C2 |
Authors
Dates
2012-12-20—Published
2008-10-15—Filed